文献速递临床试验与 GCP

低电压区消融治疗持续性心房颤动:一项随机对照试验

Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trial.
PubMed 文献 · Nat Med · 2025-04-30

SUPPRESS-AF多中心随机对照试验纳入持续性心房颤动且左心房低电压区≥5 cm²的患者,在肺静脉隔离后按1:1随机接受低电压区消融(PVI+LVA-ABL组,n=170)或不接受(单纯PVI组,n=171)。随访1年,PVI+LVA-ABL组无房颤或房性心动过速复发率61%(95%CI=53-68%)高于单纯PVI组50%(95%CI=42-57%),但差异未达统计学显著(P=0.127)。

要点

  • 持续性房颤伴左心房低电压区≥5 cm²者,PVI后加做低电压区消融未显著降低1年房颤或房性心动过速复发。
  • PVI+LVA-ABL组无复发率61% vs 单纯PVI组50%,差异未达统计学显著(P=0.127)。
  • 两组手术相关严重不良事件无差异(1.7% vs 1.8%)。

核心结论

  • 在持续性房颤伴左心房低电压区的患者中,肺静脉隔离后加做低电压区消融未显著降低1年房颤或房性心动过速复发。
  • 未来研究需要识别可能从低电压区消融中获得更大获益的患者。

研究设计与样本

  • 多中心随机对照试验(SUPPRESS-AF),纳入持续性房颤且肺静脉隔离后电压图显示左心房低电压区覆盖≥5 cm²的左心房表面的患者。
  • 患者按1:1随机分为PVI+LVA-ABL组(n=170)和单纯PVI组(n=171)。
  • 共1347例(男1003例,女344例)接受首次房颤消融的患者中,存在左心房低电压区者被分配至上述两组。
  • 采用24小时动态心电图和每日两次便携式心电图记录监测房颤或房性心动过速复发。
  • 主要终点为1年随访期间未使用抗心律失常药物情况下无房颤或房性心动过速复发。

主要发现

  • PVI+LVA-ABL组无房颤或房性心动过速复发率为61%(95%CI=53-68%),单纯PVI组为50%(95%CI=42-57%),差异未达统计学显著(P for log(rank) test=0.127)。
  • 两组手术相关严重不良事件无差异(1.7% vs 1.8%,P<0.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未来研究需要识别可能从低电压区消融中获得更大获益的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Low-voltage areas (LVAs) in the left atrium may promote atrial fibrillation (AF), but the efficacy of LVA ablation for preventing arrhythmia has not been determined. In the present study, we carried out a multicenter, randomized controlled trial (SUPPRESS-AF) to investigate the efficacy of LVA ablation in patients with persistent AF who had left atrial LVAs. Patients with persistent AF and left atrial LVAs that covered ≥5 cm2 of the left atrial surface on a voltage map after pulmonary vein isolation (PVI) were randomized to undergo LVA ablation (PVI + LVA-ABL group) or not (PVI-alone group) in a 1:1 fashion. Recurrence of AF or atrial tachycardia (AT) was monitored using 24-h Holter electrocardiography (ECG) and twice-daily portable ECG recordings. The primary endpoint was freedom from AF or AT recurrence without antiarrhythmic drug use during 1 year of follow-up. Of 1,347 patients (1,003 males and 344 females) who underwent initial ablation for AF, patients with left atrial LVAs were assigned to the PVI + LVA-ABL (n = 170) or the PVI-alone group (n = 171). Although the PVI + LVA-ABL group demonstrated a numerically higher rate of freedom from AF or AT recurrence compared with the PVI-alone group (61% (95% confidence interval (CI) = 53-68%) versus 50% (95% CI = 42-57%)), this difference did not reach statistical significance (P for log(rank) test = 0.127). There was no difference in the procedure-related serious adverse events between the two groups (1.7% versus 1.8%, P < 0.0001). In conclusion, LVA ablation in addition to PVI did not significantly reduce 1-year AF or AT recurrence in patients with persistent AF with left atrial LVAs. Future studies are needed to identify patients who may receive greater benefit from LVA ablation.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Masuda M, Sunaga A, Tanaka N, et al. Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trial. Nat Med. 2025. PMID: 40307511. doi:10.1038/s41591-025-03674-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。